Changes in insulin-like growth factor-II/mannose-6-phosphate receptor during growth and atresia of ovine ovarian follicles. 1994

M P Teissier, and P Monget, and D Monniaux, and P Durand
Station INRA de Physiologie de la Reproduction des Mammifères Domestiques, Nouzilly, France.

To assess a potential role of insulin-like growth factor (IGF)-II/mannose-6-phosphate (M6P) receptor in the ewe ovary, [125I]IGF-II binding was assessed on whole ovarian membranes and on ovarian sections. Competition studies with IGF-I, IGF-II, and insulin were performed to estimate the specificity of [125I]IGF-II binding. On the ovarian sections, labeling was quantified after microautoradiography by image analysis. In addition, immunohistochemistry experiments using a specific polyclonal antibody raised against the IGF-II/M6P receptor were performed on ovarian sections. Specific and high-affinity binding sites for IGF-II were present on whole ovarian membranes and on ovarian sections. On membranes, the Kd value was close to 0.2 nM. IGF-I was approximately 1000-fold less potent than IGF-II in displacing binding of [125I]IGF-II from whole membranes as well as from granulosa and thecal cells on ovarian sections. Insulin did not displace [125I]IGF-II binding. Cross-linking experiments followed by SDS-PAGE under reducing conditions revealed that [125I]IGF-II binding predominantly involved a 260-kDa protein, the size of which is compatible with that of the IGF-II/M6P receptor. Furthermore, both autoradiography and immunohistochemistry experiments demonstrated that IGF-II/M6P receptor was present at high levels in granulosa of atretic follicles and in theca of healthy follicles. Conversely, very low levels were found in granulosa of healthy follicles and in theca of atretic follicles. The involvement of the IGF-II/M6P receptor in ovarian tissue remodeling and in mediating IGF-II action during the processes of folliculogenesis and atresia remains to be determined.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005260 Female Females
D006080 Ovarian Follicle An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. Graafian Follicle,Atretic Follicle,Ovarian Follicles,Atretic Follicles,Follicle, Atretic,Follicle, Graafian,Follicle, Ovarian,Follicles, Atretic,Follicles, Graafian,Follicles, Ovarian,Graafian Follicles
D006107 Granulosa Cells Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH). Cell, Granulosa,Cells, Granulosa,Granulosa Cell
D000345 Affinity Labels Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. Affinity Labeling Reagents,Labeling Reagents, Affinity,Labels, Affinity,Reagents, Affinity Labeling
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M P Teissier, and P Monget, and D Monniaux, and P Durand
February 1988, Biochemical and biophysical research communications,
M P Teissier, and P Monget, and D Monniaux, and P Durand
October 1996, Developmental dynamics : an official publication of the American Association of Anatomists,
M P Teissier, and P Monget, and D Monniaux, and P Durand
June 2000, The Journal of biological chemistry,
M P Teissier, and P Monget, and D Monniaux, and P Durand
September 1993, Biochemical and biophysical research communications,
M P Teissier, and P Monget, and D Monniaux, and P Durand
December 1989, Cytotechnology,
M P Teissier, and P Monget, and D Monniaux, and P Durand
February 2006, Bioscience reports,
M P Teissier, and P Monget, and D Monniaux, and P Durand
June 2005, The Journal of biological chemistry,
M P Teissier, and P Monget, and D Monniaux, and P Durand
February 1988, The Journal of biological chemistry,
Copied contents to your clipboard!